Relevant bibliographies by topics / Yun dong yu jian kang

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Conference papers

Academic literature on the topic 'Yun dong yu jian kang'

Author: Grafiati
Published: 4 June 2021
Last updated: 28 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Yun dong yu jian kang.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Yun dong yu jian kang"

1

Shi, Xiao-Ling, Yang Kang, Yu-Ying Liu, et al. "Malaxis henanensis (Orchidaceae, Malaxideae), a new species from China." Phytotaxa 589, no. 3 (2023): 293–95. https://doi.org/10.11646/phytotaxa.589.3.9.

Full text
Abstract:
Shi, Xiao-Ling, Kang, Yang, Liu, Yu-Ying, Tu, Song, Peng, Hong-Jun, Liu, Zhong-Jian, Peng, Dong-Hui (2023): Malaxis henanensis (Orchidaceae, Malaxideae), a new species from China. Phytotaxa 589 (3): 293-295, DOI: 10.11646/phytotaxa.589.3.9, URL: http://dx.doi.org/10.11646/phytotaxa.589.3.9
APA, Harvard, Vancouver, ISO, and other styles
2

Ma, Xiaowei, Bryan D. Wood, and Brian Way. "Application of Tetraethylsulfamide (TES) As a Cathode Additive in Cylindrical Cells." ECS Meeting Abstracts MA2022-01, no. 2 (2022): 357. http://dx.doi.org/10.1149/ma2022-012357mtgabs.

Full text
Abstract:
Recently, sulfonamides have been shown to be promising electrolyte components due to their high chemical and electrochemical stability in lithium batteries [1, 2]. The electrolyte stability becomes critical when applying high voltage and/or utilizing Ni-rich layered oxides in high energy density lithium-ion batteries. Another approach to successful Ni-rich cathode performance is to develop a stable and effective cathode electrolyte interphase (CEI). Given the success of sultones and sulfates in this regard [3, 4], it is hypothesized that nitrogen analogs, like sulfonamides, could be tailored t
APA, Harvard, Vancouver, ISO, and other styles
3

Lee, Youngrae, Sujeong Baek, Dong Kwon Kim, et al. "Abstract 3234: OCT-598, a novel EP2/EP4 dual antagonist, promotes anti-tumor immune responses in syngeneic mouse tumor models in combination with standard-of-care chemo- and immunotherapies." Cancer Research 83, no. 7_Supplement (2023): 3234. http://dx.doi.org/10.1158/1538-7445.am2023-3234.

Full text
Abstract:
Abstract Prostaglandin E2 (PGE2) is widely recognized as one of the major bioactive lipids that, with the striking regenerative potential, promote drug-resistance in cancer cells as well as immune evasion in the tumor microenvironment (TME). Primarily driven by apoptotic cell death, PGE2 is thought to elicit wound-healing responses to help provide an immunosuppressive and proliferative niche that supports cancer stem cell repopulation and thereby therapy-resistance. While COX1/2 inhibitors that attenuate PGE2 production have shown promising anti-cancer effects in various (pre-)clinical setting
APA, Harvard, Vancouver, ISO, and other styles
4

Xu, Rui-Hua, Dan-Yun Ruan, Rong-Bo Lin, et al. "Abstract CT010: Phase I dose-escalation and expansion study of JS107, a claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC), as monotherapy or in combination for patients (pts) with advanced solid tumors." Cancer Research 85, no. 8_Supplement_2 (2025): CT010. https://doi.org/10.1158/1538-7445.am2025-ct010.

Full text
Abstract:
Abstract Background: JS107 is a monomethyl auristatin E conjugated, CLDN18.2 specific ADC. JS107 exhibited potent anti-tumor activities in preclinical studies with a tolerable safety profile. Here we report the safety and efficacy results of JS107 monotherapy or in combination for pts with advanced solid tumors from the first-in-human phase 1 trial (NCT05502393). Methods: In Part A of the study, pts with advanced solid tumors refractory to standard therapies were treated with JS107 at 0.15-3.5 mg/kg Q3W during dose escalation and CLDN18.2+ pts were treated with JS107 at 2.0 and 3.0 mg/kg Q3W d
APA, Harvard, Vancouver, ISO, and other styles
5

Min, Arim, Chun-bong Synn, Seong-san Kang, et al. "Abstract 6433: A novel bacterial strain, CJRB-101, induces anti-cancer effects by repolarization of M2 to CXCL9 and CXCL10 dual expressing M1 macrophages in humanized non-small cell lung cancer mice models." Cancer Research 83, no. 7_Supplement (2023): 6433. http://dx.doi.org/10.1158/1538-7445.am2023-6433.

Full text
Abstract:
Abstract Backgrounds: Live biotherapeutic products (LBPs) emerged as potential therapeutics to overcome the limitation of ICIs. This research shows that CJRB-101, a novel bacterial strain, can improve anti-tumor effects in synergy with pembrolizumab in non-small cell lung cancer (NSCLC). Objectives and Methods: Tumors from NSCLC patients (anti-PD-1 refractory and resistant) were transplanted into Hu-CD34-NSG to establish humanized patient-derived xenograft (PDX) mice models. Five models (YHIM-2003, 2004, 2009, 2010 and 2014) were treated with CJRB-101 at low (5 × 107 CFU) or high (109 CFU) dos
APA, Harvard, Vancouver, ISO, and other styles
6

Min, Arim, Bo-eun Kwon, Seong-san Kang, et al. "Abstract 4993: CJRB-101 induces immune responses through the GUT-TME axis in immune cell-driven mechanism in lung cancer models." Cancer Research 84, no. 6_Supplement (2024): 4993. http://dx.doi.org/10.1158/1538-7445.am2024-4993.

Full text
Abstract:
Abstract Background Live biotherapeutic products (LBPs) are known to enhance immune responses through the GUT-TME axis. Here, we investigate the GUT-TME-related immune cell profiling and signals associated with the anti-cancer effects of CJRB-101. Methods Tumors from NSCLC patients (anti-PD-1 refractory) were transplanted in Hu-CD34-NSG to establish humanized patient-derived xenograft (PDX) models. CJRB-101 was administered at 1x109 CFU (p.o., BID) or combination with anti-PD-1 (10 mpk, i.p., BIW). TME was analyzed using multiplex IHC, flow cytometry and scRNA sequencing. Samples were collecte
APA, Harvard, Vancouver, ISO, and other styles
7

Lee, Seul, Jae-Hwan Kim, Kwangmin Na, et al. "Abstract 6780: Characterization of immunological heterogeneity in the tumor microenvironment by integrated analyses using single cell RNAseq, spatial RNAseq and multiplex IHC." Cancer Research 83, no. 7_Supplement (2023): 6780. http://dx.doi.org/10.1158/1538-7445.am2023-6780.

Full text
Abstract:
Abstract Heterogeneity in resistant to immunotherapies of tumor microenvironment (TME) has been implicated in immunotherapies to cause immune evasion or drug resistance. This study was conducted to explore the heterogeneity of TME through multiplex IHC, spatial and RNA sequencing analysis. We selected a sample from a lung adenocarcinoma patient without EGFR-activating mutation and expressing 30% of PD-L1. For quantitative analysis by multiplex IHC, various markers including CD4, CD8, FoxP3, granzyme B, CD20 and pan-cytokeratin were stained with 7 different fluorescence dyes, which was imaged w
APA, Harvard, Vancouver, ISO, and other styles
8

Kim, Dong Kwon, Sujeong Baek, Seung Min Yang, et al. "Abstract 4039: Enhanced anti-cancer efficacy of the AhR Inhibitor DA-4505 in combination with anti-PD-1 treatment: Attenuation of lung metastasis and elimination of tumor." Cancer Research 84, no. 6_Supplement (2024): 4039. http://dx.doi.org/10.1158/1538-7445.am2024-4039.

Full text
Abstract:
Abstract Background: The Aryl hydrocarbon receptor (AhR) is one of the most predominant regulators of cancer metabolism. AhR plays a crucial role in inhibiting the activation of immune cells and promoting the growth of tumor cells. Here, we propose that a best-in-class AhR inhibitor, DA-4505, improves anti-tumor efficacy in combination with anti-PD-1. Methods: To explore the anti-tumor effects, DA-4505 was administered at a daily dose of 10 mg/kg either alone or in combination with anti-PD-1 (10 mg/kg) in a syngeneic mouse model. Tumor volume, survival rates, and metastasis were measured, and
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Yun dong yu jian kang"

1

Zhu, Jiangang. "Guo yu jia zhi jian Shanghai lin li de shi min tuan ti yu she qu yun dong de min zu zhi = Between the family and the state : an ethnography of the civil associations and community movements in a Shanghai lilong neighborhood /." online access from Digital dissertation consortium, 2002. http://libweb.cityu.edu.hk/cgi-bin/er/db/ddcdiss.pl?3066642.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Yun dong yu jian kang"

1

Nagler, Willibald. Jian yi jian kang yu kang fu yun dong jin nang. Wan li ji gou, Wan li shu dian, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

hua, Song zhen. Jian shen yun dong sun shang de yu fang yu kang fu. Ren min wei sheng chu ban she, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

jing, Fan hui. You er yuan jian kang jiao yu huo dong zhi dao. Ren min jiao yu chu ban she, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sun, Zixue. Yi ben shu du dong sheng yi ge cong ming jian kang de hai zi. Zhong yuan nong min chu ban she, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Song, Qinghong. Kang Ri zhan zheng yu nü xing dong yuan: Xin yun fu nü zhi dao wei yuan hui yan jiu = KangRi zhanzheng yu nüxing dongyuan. Shanghai da xue chu ban she, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

translator, Wu Peiyu, ed. Ru suan: Ru suan 70 wen da jie mi, liao jie ru suan yu yun dong, pi lao, jian kang de guan xi. Chen xing chu ban you xian gong si, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cai, Bo Hui. Yun dong yu bao jian. Miong Chang, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

lin, Zhou chuan. "Yun" dong ma mi geng jian kang. Xin shi jie chu ban she, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

zhou, Deng xing. Yun yu jian kang zhi nan. Zhong guo ren kou chu ban she, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

fang, Zhang. Jian kang zai yu nei dong. Si chuan ren min chu ban she, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Conference papers on the topic "Yun dong yu jian kang"

1

Xiaozhi Wang and Neil Pegg, ISSC 2022 Editors. "Proceedings of the 21st International Ship and Offshore Structures Congress VOLUME 3 Discussions." In 21st International Ship and Offshore Structures Congress Volume 3 Discussions. SNAME, 2022. http://dx.doi.org/10.5957/issc-2022-discussion-vol-3.

Full text
Abstract:
Committee I.1: Environment Alexander Babanin (Chair); Mariana Bernardino; Franz von Bock und Polach; Ricardo Campos,; Jun Ding; Sanne van Essen; Tomaso Gaggero; Maryam Haroutunian; Vanessa Katsardi; Alexander Nilva; Arttu Polojarvi; Erik Vanem; Jungyong Wang; Huidong Zhang; Tingyao Zhu Floor Discussers: Florian Sprenger; Carlos Guedes Soares; Henk den Besten Committee I.2: Loads Ole Andreas Hermundstad (Chair); Shuhong Chai; Guillaume de Hauteclocque; Sheng Dong; Chih-Chung Fang; Thomas B. Johannessen; Celso Morooka; Masayoshi Oka; Jasna Prpić-Oršić; Alessandro Sacchet; Mahmud Sazidy; Bahadir
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Yun dong yu jian kang' for particular source types:
Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography